Abraham Chaibi is cofounder and CEO of Sapho Bio. The San Carlos company automates qc workflows for pharmaceutical companies and serves 30 enterprise customers. Its rapid sterility method returns results in 2 days, compared with 14 for the standard USP<71> method.
He arrived at biotech through software. As cofounder and CTO of Dexterity Capital from 2017 to 2024, he led the engineering behind the firm's low-latency trading platform, which traded more than $2 trillion and managed $300 million. Earlier, he built data systems at LiveRamp and worked on optimization problems, NFL scheduling among them, for an analytics consultancy.
Abraham holds a BSE in mechanical engineering, cum laude. He is a licensed pilot.
Cofounded a high-frequency trading firm and led the engineering behind its low-latency trading platform. Wrote more than 100,000 lines of automated trading software that traded more than $2 trillion, and managed $300 million across dozens of exchanges with millisecond response times. Built a team of more than 30 engineers and traders, and deployed a 10,000-core data center that cut model-fitting costs by 90% compared with cloud providers.